Immune Inc.
Generated 5/11/2026
Executive Summary
Immune Inc. is a specialized consulting and software firm serving the life sciences industry, headquartered in Carlsbad, California. Founded in 2020, the company assists pharmaceutical, medical device, and biotechnology organizations in achieving regulatory compliance, implementing quality management systems, and preparing for audits. Its proprietary electronic quality management system (EQMS), FreeQMS, complements its consulting services, offering a digital solution for managing quality processes. As a private company with limited public information, Immune Inc. operates in a niche market where demand for regulatory expertise and digital quality tools is driven by increasing FDA and international compliance requirements. The company's focus on early-stage and mid-sized life sciences firms positions it for steady growth, though its lack of disclosed funding, valuation, or revenue details makes it difficult to assess its market traction. Nonetheless, the combination of consulting and software provides a recurring revenue model and potential for scalability as the life sciences sector continues to emphasize compliance and quality.
Upcoming Catalysts (preview)
- TBDLaunch of new FreeQMS features or modules20% success
- TBDMajor client contract win or partnership15% success
- TBDExpansion into new therapeutic areas or geographies10% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)